Effects of Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 in Cell-free Recombinant Reverse Transcriptase Assays

This publication has 27 references indexed in Scilit:

• Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside Inhibitors
  Science, 1995
• Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine
  Antimicrobial Agents and Chemotherapy, 1994
• Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913
  AIDS Research and Human Retroviruses, 1994
• Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
  Science, 1992
• A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site
  Biochemistry, 1991
• Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
  Science, 1989
• Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy
  AIDS, 1989
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase
  Antimicrobial Agents and Chemotherapy, 1987
• Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
  Proceedings of the National Academy of Sciences, 1986